Ablynx
Merck Serono eyes ‘Nanobody’ potential in rheumatology
October 14, 2010Research and Development Ablynx, Merck Serono
Merck Serono has expanded its research with Ablynx and will co-develop ‘Nanobodies’ from the Belgian biotech against an inflammatory disease …
Boehringer selects lead candidate for Alzheimer’s
May 24, 2010Research and Development Ablynx, Boehringer
Boehringer Ingelheim has selected a lead candidate for further development to treat Alzheimer’s disease from its collaboration with Ablynx. Belgium-based …
Next generation monoclonal antibodies to enter clinical trials in 2007
January 20, 2006Research and Development Ablynx, Novartis
Novartis has signed a deal with Belgium biotech Ablynx to develop the next generation of monoclonal antibodies with clinical development …
Latest content
Long-acting therapies set to reshape HIV treatment market
August 21, 2026
MHRA approves Romvimza for tenosynovial giant cell tumour
August 20, 2026
